Abstract
It is estimated that in the Asia-Pacific region, more than 5.2 million persons are suffering from familial hypercholesterolemia (FH). This means that more than half of the estimated world total of 10 million FH patients are living in this part of the world, of which the vast majority is not aware of their dangerous condition, let alone being adequately treated. Obviously, an intensive case-finding program to identify patients and subsequent clinical management are required to prevent premature cardiovascular disease and death caused by the consequences of inherited hypercholesterolemia. This article describes the current situation concerning FH and the initiatives and actions undertaken in Australia to contribute to actively identifying patients with FH in that country.
| Original language | English |
|---|---|
| Pages (from-to) | 87-92 |
| Number of pages | 6 |
| Journal | Seminars in Vascular Medicine |
| Volume | 4 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Feb 2004 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Asia-Pacific
- Cardiovascular disease
- Case-finding
- Familial hypercholesterolemia
Fingerprint
Dive into the research topics of 'Case-Finding for Familial Hypercholesterolemia in the Asia-Pacific Region'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver